5-(3,4,5-trimethoxyphenyl)-1,3,4-thiadiazol-2-amine, 95.0%, 10g

N-benzyl-4-fluorobenzo[d]thiazol-2-amine, 95.0%, 250mg

Ethyl 5-methoxypyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 5g

(1-(4-Bromophenyl)-1H-pyrazol-3-yl)methanamine dihydrochloride, 98%, 100mg

4-((4,4-Dimethylpiperidin-1-yl)methyl)-2-methoxybenzoic acid, 98%, 25mg

Acoplamiento rápido Conexión macho recta, Gesch. para, Manguera interior 3,2 mm, sí, 1 pieza

N-(cyclopropylmethyl)-N-[(1-methyl-1H-pyrazol-4-yl)methyl]piperidin-4-amine, 95.0%, 250mg

2,5-Bis(1,1,3,3-tetramethylbutyl)hydroquinone>95.0%(GC)5g

4-(2,6-Dichloropyrimidin-4-yl)morpholine, 95.0%, 5g

1-Cyano-4-fluoronaphthalene, 97.0%, 5g

4-Nitrophenyl beta-D-Xylopyranoside [Substrate for beta-Xylosidase]>98.0%(HPLC)100mg

2,5-Bis(2-ethylhexyl)-3,6-di(thiophen-2-yl)pyrrolo[3,4-c]pyrrole-1,4(2H,5H)-dione, 95%, 5g

2,5-Difluorobenzohydrazide, 95.0%, 31g